By Science 37
Report updated May 25, 2026
Science 37 Clinical Research
For clinical trial participants requiring remote access to study procedures and pharmaceutical sponsors seeking decentralized trial solutions.
Science 37 Clinical Research is an established health & fitness app that is completely free. With a 3.6/5 rating from 165 reviews, it shows polarized user reception. Users particularly appreciate convenience of remote participation, though technical friction during assessment tasks remains a common concern.
What is Science 37 Clinical Research?
Science 37 is a clinical research participant app for iOS and Android that enables remote trial assessments and study team communication.
Users hire the app to complete mandatory clinical trial tasks from home, replacing the need for travel to physical research sites.
Current Momentum
v3.45 · 6mo ago
Maintenance- Maintains stable core trial functionality.
- Ships periodic stability updates.
Active Nemesis
Fragmented niche
No dominant direct rival identified yet — see Other Rivals below.
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Centralized platform for clinical trial participation, including remote assessments and study documentation.
Access to a network of 150+ trained nurses for home-based clinical procedures.
How much does it cost?
- Free app for study participants
The app functions as a free utility for trial participants, with monetization occurring via B2B service contracts with pharmaceutical sponsors.
Who Built It?
Enrichment in progress
Publisher profile available very soon
What other apps does Science 37 make?
What do users think recently?
Medium confidence · 53 reviews analyzed · Based on 53 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate convenience of remote participation, but report technical friction during assessment tasks.
What Users Love
What Frustrates Users
What is the competitive landscape for Science 37 Clinical Research?
How's The Health & Fitness Market?
Market outlook for this category
Available very soon
The rivals identified
Peers
Utilizes real-time adaptive soundscapes to influence user mood, whereas Science 37 focuses on clinical trial data collection.
Offers standalone Apple Watch functionality, providing a seamless wearable experience that Science 37 currently lacks for participants.
Portal Pacjenta CMP
★4.5 (964)Centrum Medyczne CMP
🚀This portal serves as a central hub for patient medical records and appointment management, directly competing with Science 37's goal of being a one-stop clinical interface.
Includes a dietary module and self-registration features that expand the app's utility beyond simple clinical trial participation.
Maintains a high release cadence with five updates in six months, demonstrating superior responsiveness to user feedback and bugs.
TruHearing App
★4.2 (5K)Sivantos Pte. Ltd.
TruHearing overlaps with Science 37 by facilitating remote medical care and virtual appointments, directly competing for the user's time in a clinical context.
Integrates TeleCare and virtual appointments directly, creating a more robust remote clinical ecosystem than Science 37's current task-based app.
Boasts a significantly higher review volume, indicating a more mature and trusted patient-facing medical support infrastructure.
myRemote App
Sivantos Pte. Ltd.
This app competes in the medical space by providing remote device management, mirroring the remote-first philosophy of Science 37's clinical platform.
Provides granular hardware control for medical devices, a feature set distinct from Science 37's assessment-focused mobile interface.
Focuses on immediate patient-device interaction rather than the longitudinal data collection required for clinical research studies.
New Kids on the Block
Features a 'Lola' companion and mood check-ins, prioritizing emotional engagement over the functional data entry required by Science 37.
GotCGM Watchface Digital
0Gluroo Imaginations Inc.
This app represents the growing trend of wearable-first health monitoring, which threatens to displace manual clinical assessments with automated sensor data.
Leverages Wear OS complications for passive data monitoring, reducing the user friction associated with Science 37's manual assessment tasks.
The outtake for Science 37 Clinical Research
Strengths to defend, gaps to attack
Core Strengths
- 150+ research-grade nursing network enables decentralized trial execution
- Centralized platform architecture supports complex longitudinal data collection
Critical Frictions
- 0.28 rating gap between iOS and Android platforms
- No wearable integration for passive data collection
- Manual assessment-heavy interface increases user friction
Growth Levers
- Integrate wearable sensor data to automate manual assessments
- Expand B2B partnerships into broader patient-management services
Market Threats
- Wearable-first health monitoring apps displacing manual data entry
- High-cadence medical portals capturing patient attention via daily-use modules
What are the next best moves?
Audit Android stability because of the 0.28 rating gap vs iOS → improve platform parity
The rating delta between platforms indicates significant Android-specific technical friction.
Trade-off: Pause new feature development for the nursing network dashboard — stability is the current retention priority.
Ship wearable integration for passive data collection because manual assessment friction is the top complaint → reduce user churn
Competitors like Endel and Gluroo leverage passive data, exposing Science 37's manual-only interface as a competitive weakness.
Trade-off: Deprioritize the UI refresh of the study documentation module — wearable data has higher impact on participant retention.
A counter-intuitive read
The platform's B2B-only monetization model is a strategic liability, as it removes the incentive to build the high-frequency engagement loops that keep patients active in competing medical portals.
Feature Gaps vs Competitors
- Wearable-first data collection (available in Endel and Gluroo but absent here)
- Daily-use health modules (available in Portal Pacjenta CMP but absent here)
Key Takeaways
Science 37 holds a unique position in decentralized trials through its nursing network, but the manual-heavy interface creates churn risk against wearable-first competitors, so the PM must prioritize passive data integration to secure long-term participant retention.
Where Is It Heading?
Mixed Signals
The decentralized clinical trial market is shifting toward automated, wearable-first data collection to reduce participant burden. Science 37's current manual-only assessment model leaves it exposed to competitors that offer more passive and integrated patient experiences, so the platform must pivot to wearable support to maintain its B2B value proposition.
The Android rating gap persists, indicating that technical debt in the latest release is eroding the user experience for the majority base.
Recent updates focus on stability rather than feature expansion, suggesting the platform is in a maintenance phase rather than active growth.